FDA Proposes Removal of Decongestants in Cold and Allergy Medications

Removal of Decongestants

In a significant move, the FDA has proposed the removal of decongestants from many over-the-counter (OTC) cold and allergy medications. This decision addresses concerns about their effectiveness. The FDA found insufficient evidence to support their ability to provide relief. Why is the FDA Proposing This Change? The FDA’s proposed action follows a comprehensive review of […]

Flu Shot Effectiveness on a Downward Trend, CDC Data Suggests

flu shot effectiveness

As the flu season picks up in the U.S., recent data from the CDC indicates this year’s flu shot effectiveness may be lower than anticipated. With early reports suggesting a downward trend in protection, healthcare providers are now facing questions about how to best safeguard against the influenza virus, especially for vulnerable populations. Fluctuations in Flu […]

Supply Chain Disruptions and Rising Costs of APIs: A Challenge for the Pharmaceutical Industry

Rising Costs of APIs

The pharmaceutical industry has been facing significant supply chain disruptions in recent years, with rising costs of APIs (active pharmaceutical ingredients) becoming a major concern. These disruptions are primarily caused by several factors, including natural disasters in the U.S., port congestion, and global instability. For companies like UDose™ that rely on a consistent supply of […]